In episode two, Steve Bland explores the exciting new Galleri Trial announced by NHS England and healthcare company GRAIL UK, which could see a single blood test used to spot the early signs of 50 cancers, including some of the most difficult to diagnose and detect.
The trial is being rolled out in eight parts of the country, and one of those is right here in Greater Manchester. Steve gets the lowdown on the science from Sara Hiom, the Director of Cancer Intelligence at GRAIL, finds out how it will work on the ground from Dr Matthias Hohmann, who is a GP in Oldham and the Clinical Director for Cancer at Oldham CCG, and gets the thoughts of patient Julie Colville.
For more information about GM Cancer click here.
And to find out about the Galleri Trial, visit NHS-Galleri Trial | Detecting cancer early.
Information
- Show
- FrequencyMonthly
- Published6 October 2021 at 09:10 UTC
- Length34 min
- Episode2
- RatingClean